Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Vertex Pharmaceuticals Inc VRTX

Healthcare Biotechnology
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VRTX)

Vertex to Participate in Upcoming March Investor Conferences

Business Wire 2 days ago

Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures

Business Wire 2 days ago

Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3

Business Wire February 17, 2026

Vertex Reports Fourth Quarter and Full Year 2025 Financial Results

Business Wire February 12, 2026

Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th

Business Wire January 20, 2026

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Business Wire January 11, 2026

Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12

Business Wire December 22, 2025

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions

Business Wire December 6, 2025

Vertex to Participate in the Citi's 2025 Global Healthcare Conference on December 3

Business Wire November 19, 2025
View More News ››

Opinion & Analysis (NDAQ:VRTX)

Don't Overlook Mid-Cap Stocks

Benzinga.com  December 11, 2014

Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary

Benzinga.com  June 26, 2014

Stock picks including a coal play

J.W. Cotton November 4, 2009
View More Opinion ››

Bullboard Posts (NDAQ:VRTX)

Keep steady

Bought in today. Do not overreact to the news. Firstly sciatic studies are well known for high placebo responder groups. The current...
gourt12 - December 19, 2024

VRTX: Strong Growth, But Watch the Pipeline

VRTX is on fire right now with their CF portfolio—Trikafta is still bringing in the revenue. But the real play could be in their gene...
SmartBull65 - November 30, 2024

Vertex Pharmaceuticals (NASDAQ:VRTX) &#8211; A Diversified P

http://beyondspx.com/2024/08/02/vertex-pharmaceuticals-nasdaqvrtx-a-diversified-powerhouse-delivering-transformative-medicines/
MikeTester - August 3, 2024

Very Bullish

Glad I bought some in March! who will lead in treating CF? VRTX or KRYS? Both show huge potential 
TechTitan - July 15, 2023

Benefits of Rare Cannabinoids

Big Pharma is about to get into research of a new class of drugs, rare Cannabinoids, a $10B market by 2025. Vertex would benefit from...
Bullknit101 - September 26, 2021

Bonvoyage12....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020
View more Bullboard ››

Silver North Resources Ltd.

Silver North Resources Ltd.

Silver North Resources Ltd., an exploration stage company, acquires and explores mineral properties. It explores for gold ...
View More »

Podcasts